Premium
Use of a yeast assay to detect functional alterations in p53 in prostate cancer: Review and future directions
Author(s) -
deVere White Ralph W.,
Deitch Arline D.,
Gumerlock Paul H.,
Shi XuBao
Publication year - 1999
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/(sici)1097-0045(19991001)41:2<134::aid-pros8>3.0.co;2-e
Subject(s) - prostate cancer , mutant , biology , androgen receptor , cancer , computational biology , mechanism (biology) , yeast , genetics , mutation , single strand conformation polymorphism , cancer research , prostate , bioinformatics , gene , philosophy , epistemology
BACKGROUND While many studies have suggested that p53 mutations are common in human cancers, the functional activity of these mutant alleles has not yet been fully addressed. We believe that information about the functional status of individual p53 mutants will prove to be important for a better understanding of the role of p53 in tumor development and progression. Ultimately, this information could also influence treatment decisions for individual cancer patients. METHODS A recently developed yeast functional assay can be used to assess the transactivational activity of p53 mutants. Furthermore, this assay is more sensitive than single strand conformational polymorphism (SSCP) for detection of p53 mutations. In this review, we summarize the mechanism of this new technique and describe its applications in cancer research, with an emphasis on prostate cancer. RESULTS The use of the yeast functional assay provides a simple, sensitive, and reproducible method for detecting p53 mutations and for determining the transactivational activity and dominant‐negative role of individual p53 mutants. CONCLUSIONS This method may be adapted to analyze other transcriptional factors, including the human androgen receptor. Prostate 41:134–142, 1999. © 1999 Wiley‐Liss, Inc.